IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models
Patients with small cell lung cancer (SCLC) generally have a poor prognosis and a median overall survival of only about 13 months, indicating the urgent need for novel therapies. Delta-like protein 3 (DLL3) has been identified as a tumor-specific cell surface marker on neuroendocrine cancers, includ...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Clinical Investigation
2023-05-01
|
| Series: | The Journal of Clinical Investigation |
| Subjects: | |
| Online Access: | https://doi.org/10.1172/JCI166028 |
| _version_ | 1797634413465436160 |
|---|---|
| author | Janneke E. Jaspers Jonathan F. Khan William D. Godfrey Andrea V. Lopez Metamia Ciampricotti Charles M. Rudin Renier J. Brentjens |
| author_facet | Janneke E. Jaspers Jonathan F. Khan William D. Godfrey Andrea V. Lopez Metamia Ciampricotti Charles M. Rudin Renier J. Brentjens |
| author_sort | Janneke E. Jaspers |
| collection | DOAJ |
| description | Patients with small cell lung cancer (SCLC) generally have a poor prognosis and a median overall survival of only about 13 months, indicating the urgent need for novel therapies. Delta-like protein 3 (DLL3) has been identified as a tumor-specific cell surface marker on neuroendocrine cancers, including SCLC. In this study, we developed a chimeric antigen receptor (CAR) against DLL3 that displays antitumor efficacy in xenograft and murine SCLC models. CAR T cell expression of the proinflammatory cytokine IL-18 greatly enhanced the potency of DLL3-targeting CAR T cell therapy. In a murine metastatic SCLC model, IL-18 production increased the activation of both CAR T cells and endogenous tumor-infiltrating lymphocytes. We also observed an increased infiltration, repolarization, and activation of antigen-presenting cells. Additionally, human IL-18–secreting anti-DLL3 CAR T cells showed an increased memory phenotype, less exhaustion, and induced durable responses in multiple SCLC models, an effect that could be further enhanced with anti–PD-1 blockade. All together, these results define DLL3-targeting CAR T cells that produce IL-18 as a potentially promising novel strategy against DLL3-expressing solid tumors. |
| first_indexed | 2024-03-11T12:08:28Z |
| format | Article |
| id | doaj.art-1add364070234a5a9f42731c9c6e16d1 |
| institution | Directory Open Access Journal |
| issn | 1558-8238 |
| language | English |
| last_indexed | 2024-03-11T12:08:28Z |
| publishDate | 2023-05-01 |
| publisher | American Society for Clinical Investigation |
| record_format | Article |
| series | The Journal of Clinical Investigation |
| spelling | doaj.art-1add364070234a5a9f42731c9c6e16d12023-11-07T16:20:16ZengAmerican Society for Clinical InvestigationThe Journal of Clinical Investigation1558-82382023-05-011339IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer modelsJanneke E. JaspersJonathan F. KhanWilliam D. GodfreyAndrea V. LopezMetamia CiampricottiCharles M. RudinRenier J. BrentjensPatients with small cell lung cancer (SCLC) generally have a poor prognosis and a median overall survival of only about 13 months, indicating the urgent need for novel therapies. Delta-like protein 3 (DLL3) has been identified as a tumor-specific cell surface marker on neuroendocrine cancers, including SCLC. In this study, we developed a chimeric antigen receptor (CAR) against DLL3 that displays antitumor efficacy in xenograft and murine SCLC models. CAR T cell expression of the proinflammatory cytokine IL-18 greatly enhanced the potency of DLL3-targeting CAR T cell therapy. In a murine metastatic SCLC model, IL-18 production increased the activation of both CAR T cells and endogenous tumor-infiltrating lymphocytes. We also observed an increased infiltration, repolarization, and activation of antigen-presenting cells. Additionally, human IL-18–secreting anti-DLL3 CAR T cells showed an increased memory phenotype, less exhaustion, and induced durable responses in multiple SCLC models, an effect that could be further enhanced with anti–PD-1 blockade. All together, these results define DLL3-targeting CAR T cells that produce IL-18 as a potentially promising novel strategy against DLL3-expressing solid tumors.https://doi.org/10.1172/JCI166028ImmunologyOncology |
| spellingShingle | Janneke E. Jaspers Jonathan F. Khan William D. Godfrey Andrea V. Lopez Metamia Ciampricotti Charles M. Rudin Renier J. Brentjens IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models The Journal of Clinical Investigation Immunology Oncology |
| title | IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models |
| title_full | IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models |
| title_fullStr | IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models |
| title_full_unstemmed | IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models |
| title_short | IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models |
| title_sort | il 18 secreting car t cells targeting dll3 are highly effective in small cell lung cancer models |
| topic | Immunology Oncology |
| url | https://doi.org/10.1172/JCI166028 |
| work_keys_str_mv | AT jannekeejaspers il18secretingcartcellstargetingdll3arehighlyeffectiveinsmallcelllungcancermodels AT jonathanfkhan il18secretingcartcellstargetingdll3arehighlyeffectiveinsmallcelllungcancermodels AT williamdgodfrey il18secretingcartcellstargetingdll3arehighlyeffectiveinsmallcelllungcancermodels AT andreavlopez il18secretingcartcellstargetingdll3arehighlyeffectiveinsmallcelllungcancermodels AT metamiaciampricotti il18secretingcartcellstargetingdll3arehighlyeffectiveinsmallcelllungcancermodels AT charlesmrudin il18secretingcartcellstargetingdll3arehighlyeffectiveinsmallcelllungcancermodels AT renierjbrentjens il18secretingcartcellstargetingdll3arehighlyeffectiveinsmallcelllungcancermodels |